Niagen Bioscience, Inc.
جودة البيانات: 100%
NAGE
NASDAQ
Manufacturing
Chemicals
KWD 4.74
▲
KWD 0.05
(1.07%)
6 months return
—
Momentum
Neutral
5Y revenue growth
17.70%
النمو
Revenue Growth (5Y)
17.70%
أعلى من متوسط القطاع (1.72%)
Revenue (1Y)29.95%
Earnings (1Y)103.30%
FCF Growth (3Y)37.75%
الجودة
Return on Equity
25.78%
أعلى من متوسط القطاع (-54.68%)
ROIC21.51%
Net Margin13.43%
Op. Margin12.58%
الأمان
Debt / Equity
N/A
Current Ratio4.12
Interest CoverageN/A
التقييم
PE (TTM|NTM|2027)
20.69 | 14.81 | 14.03
أعلى من متوسط القطاع (-1.50)
P/B Ratio5.09
EV/EBITDA18.15
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 17.70% annually over 5 years — strong growth
Earnings grew 103.30% over the past year
ROE of 25.78% indicates high profitability
Generating 13.50 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 12.25%
ROIC of 21.51% — excellent capital efficiency
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
5 محللين
Buy
+186.9%
upside to target
الحالي
KWD 4.74
Consensus Target
KWD 13.60
KWD 12.00
أدنى
KWD 18.00
أعلى
التوقعات
مكرر الربحية المستقبلي
14.81
ربحية السهم المستقبلية
KWD 0.32
نمو ربحية السهم (تقدير)
+33.3%
الإيرادات المقدّرة
171.74 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: KWD 0.06
·
Rev Est: 30.36 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | KWD 0.05 | KWD 0.04 | KWD 0.05 | KWD 0.03 | — | — |
| Estimate | KWD 0.02 | KWD 0.01 | KWD 0.02 | KWD 0.02 | KWD 0.06 | KWD 0.03 |
| المفاجأة | +172.35% | +499.70% | +233.33% | +65.57% | — | — |
Growth
Rev 5Y: 17.70% · Earnings 1Y: 103.30%
Growth
Rev 5Y: 17.70% · Earnings 1Y: 103.30%| Revenue Growth (1Y) | 29.95% | Revenue Growth (3Y) | 24.45% |
| Earnings Growth (1Y) | 103.30% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17.70% | Earnings Growth (5Y) | N/A |
Profitability
ROE: 25.78% · Net Margin: 13.43%
Profitability
ROE: 25.78% · Net Margin: 13.43%| Revenue (TTM) | 129.42 M | Net Income (TTM) | 17.38 M |
| ROE | 25.78% | ROA | 18.33% |
| Gross Margin | 64.28% | Operating Margin | 12.58% |
| Net Margin | 13.43% | Free Cash Flow (TTM) | 13.50 M |
| ROIC | 21.51% | FCF Growth (3Y) | 37.75% |
Safety
D/E: N/A · Current: 4.12
Safety
D/E: N/A · Current: 4.12| Debt / Equity | N/A | Current Ratio | 4.12 |
| Interest Coverage | N/A | Asset Turnover | 1.36 |
| Working Capital | 70.90 M | Tangible Book Value | 70.43 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: 20.69 · EV/EBITDA: 18.15
Valuation
P/E: 20.69 · EV/EBITDA: 18.15| P/E Ratio | 20.69 | Forward P/E | 14.81 |
| P/B Ratio | 5.09 | P/S Ratio | 2.78 |
| PEG Ratio | N/A | Forward PEG | 0.44 |
| EV/EBITDA | 18.15 | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.09 | Fwd Earnings Yield | 6.75% |
| FCF Yield | 3.76% | ||
| Market Cap | 359.56 M | Enterprise Value | 295.46 M |
Per Share
EPS: 0.20 · FCF/Share: 0.17
Per Share
EPS: 0.20 · FCF/Share: 0.17| EPS (Diluted TTM) | 0.20 | Revenue / Share | 1.62 |
| FCF / Share | 0.17 | OCF / Share | 0.17 |
| EPS CAGR (1Y) | 81.82% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 77.69% · CapEx/Rev: N/A
Efficiency
FCF Conv: 77.69% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 77.69% |
| SBC-Adj. FCF | 8.45 M | Growth Momentum | 12.25 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 129.42 M | 99.60 M | 83.57 M | 72.05 M | 67.45 M |
| Net Income | 17.38 M | 8.55 M | -4.94 M | -16.54 M | -27.13 M |
| EPS (Diluted) | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
| Gross Profit | 83.19 M | 61.59 M | 50.78 M | 42.80 M | 41.49 M |
| Operating Income | 16.28 M | 7.73 M | -5.60 M | -18.63 M | -27.07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 6.33 M | 6.02 M | 4.96 M | 4.83 M | 3.83 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | 661,000.0 | 3,000.0 | 55,000.0 |
| Income Tax | 810,000.0 | 305,000.0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 106.41 M | 68.28 M | 54.96 M | 54.06 M | 57.84 M |
| Total Liabilities | 29.87 M | 22.18 M | 26.51 M | 25.39 M | 26.11 M |
| Shareholders' Equity | 76.53 M | 46.09 M | 28.46 M | 28.67 M | 31.73 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | 44.50 M | 27.20 M | 20.30 M | 28.22 M |
| Current Assets | 96.81 M | 64.10 M | 49.53 M | 46.57 M | 48.91 M |
| Current Liabilities | 19.92 M | 17.95 M | 20.62 M | 17.87 M | 17.61 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 20.7 | -1.5 |
| P/B | 5.1 | 1.6 |
| ROE % | 25.8 | -54.7 |
| Net Margin % | 13.4 | -41.5 |
| Rev Growth 5Y % | 17.7 | 1.7 |
| D/E | — | 0.3 |
درجات الاستراتيجيات
2 strategies matched
درجات الاستراتيجيات
2 strategies matched
#41 of 69
#41 of 69
النشاط الأخير
دخل
Mahmoud's Growth Investing (Philip Fisher)
Apr 12, 2026
دخل
Growth Investing (Philip Fisher)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"NAGE","listing_kind":"stock","pathname":"/stocks/nage","exchange":"NASDAQ","country":"US"}}